ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "innate immunity"

  • Abstract Number: 1712 • ACR Convergence 2023

    Identification and Functional Characterization of Eight CANDLE/PRAAS Causing Proteasome Variants in Five Unrelated Patients

    Adriana Almeida de Jesus1, Jonas J. Papendorf2, Frederic Ebstein3, Sara Alehashemi4, Daniela Pioto5, Anna Kozlova6, Maria Teresa TErreri7, Anna Shcherbina6, Andre Rastegar8, Marta Rodrigues9, Renan Pereira10, Sophia Park11, Bin Lin12, Kat Uss11, Ana Flavia da Silva Pina5, FLAVIO SZTAJNBOK13, Sofia Torreggiani14, Jennifer Stoddard15, Julie Niemela15, Sergio Rosenzweig15, Adriana Fonseca16, Marietta De Guzman17, Nicole Micheloni5, Melissa Fraga5, Sandro Perazzio18, Raphaela Goldbach-Mansky19 and Elke Krueger2, 1NIAID, NIH, Bethesda, MD, 2Institut für Medizinische Biochemie und Molekularbiologie (IMBM), Universitätsmedizin Greifswald, Greifswald, Germany, 3Nantes Université, Nantes, France, 4NIH/NIAID/TADS, Clarksville, MD, 5Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil, 6Center for Pediatric Hematology, Oncology, Immunology, Moscow, Russia, 7UNIFESP, São Paulo, Brazil, 8NIH, Bethesda, MD, 9Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil, 10Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, 11Translational Autoinflammatory Diseases Section, LCIM, NIAID, NIH, Bethesda, MD, 12Translational Autoinflammatory Diseases Section l LCIM, NIAID, NIH, Bethesda, MD, 13UFRJ/UERJ, São Paulo, Brazil, 14University of Maryland Baltimore, Baltimore, MD, 15Department of Laboratory Medicine, Clinical Center, NIH, Bethesda, MD, 16Instituto de Puericultura e Pediatria Martagao Gesteira / Universidade Federal do Rio de Janeiro, Rio De Janeiro, Brazil, 17Baylor College of Medicine, Houston, TX, 18Universidade de Sao Paulo (Unifesp); Universidade de São Paulo (USP); Fleury Laboratories, São Paulo, Brazil, 19NIH/NIAID, Potomac, MD

    Background/Purpose: Mutations in genes coding for 20S proteasome subunits or proteasome assembly helpers cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperatures (CANDLE) or…
  • Abstract Number: 0796 • ACR Convergence 2023

    Role of Group 2 Innate Lymphoid Cells in the Pathogenesis of Rheumatoid Arthritis

    Anders Nguyen1, Agnieszka Lastowska1, Miriam Bollmann1, Symeon Kourmoulakis1, Charlotte E. van der Plas1, Anna-Karin Hultgård Ekwall2, Dietmar M. Zaiss3, Gary S Firestein4 and Mattias N.D Svensson5, 1Department of Rheumatology and Inflammation research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, 2Department of Rheumatology and Inflammation research, Sahlgrenska Academy, University of Gothenburg, Kullavik, Sweden, 3Faculty of Medicine, Department of Immune Medicine, University of Regensburg, Regensburg, Germany, Regensburg, Germany, 4Department of Medicine, University of California San Diego, La Jolla, CA, 5University of Gothenburg, Gothenburg, Sweden

    Background/Purpose: Immune-cell mediated activation of joint-lining fibroblast-like synoviocytes (FLS) play a key role in joint inflammation and destruction during Rheumatoid arthritis (RA). Thus, identifying factors…
  • Abstract Number: 1761 • ACR Convergence 2023

    JAK/STAT Inhibition Modifies the Innate Lymphoid Cells 1 Immune Response in Patients with Rheumatoid Arthritis

    Lidia La Barbera1, Marianna Lo Pizzo1, Chiara Rizzo1, Leila Mohammadnezhad1, federica Camarda1, Francesco Ciccia2 and Giuliana Guggino1, 1University of Palermo, Palermo, Italy, 2University of Campania - Luigi Vanvitelli, Naples, Italy

    Background/Purpose: Recent evidence suggests that innate lymphoid cells (ILCs) might be involved in rheumatoid arthritis (RA) pathogenesis and individuals at risk of RA exhibited an…
  • Abstract Number: 0881 • ACR Convergence 2023

    Deficiency of the Pattern-recognition Receptor CD14 Protects Against LPS-induced Inhibition of Osteoclastogenesis in Vitro

    Lance Murphy1, Kevin Burt2, Baofeng Hu3, Vu Nguyen2, Robert Mauck2 and Carla Scanzello2, 1University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 2University of Pennsylvania, Philadelphia, PA, 3University of Pennsylvania, Wynnewood, PA

    Background/Purpose: Osteoarthritis is associated with bone changes such as subchondral sclerosis, bone marrow lesions, and osteophyte formation (Donel S, 2019). Prior work has demonstrated that…
  • Abstract Number: 2206 • ACR Convergence 2023

    Increased Frequency of Activated MAIT Cells Expressing the Gut Homing Receptor CCR9 in Patients with Radiographic Axial Spondyloarthritis

    Eric Toussirot1, Caroline Laheurte2, Eléonore Gravelin2, Charline Vauchy3, Marc Puyraveau3 and Philippe Saas4, 1University Hospital of Besancon, Besançon, France, 2INSERM UMR1098, plateforme de biomonitoring, EFS Bourgogne-Franche-Comté, Besançon, France, 3INSERM CIC-1431, Besançon, France, 4INSERM UMR1098, EFS Bourgogne-Franche-Comté, Besançon, France

    Background/Purpose: MAIT (mucosal associated invariant T) cells are involved in mucosa defense against bacteria. This cellular subset is characterized by a semi-invariant αβ TCR and…
  • Abstract Number: 0888 • ACR Convergence 2023

    Functionally Selective Immunomodulator Shows Robust Efficacy in Spontaneous Lupus Mouse Model

    Helene ASNAGLI1, Simon TESSIER1, Martyn FOSTER2, Sofie DENIES3, Eef HOEBEN4, Joël CROUZET1 and Annegret VAN DER AA1, 1Ermium Therapeutics, Paris, France, 2Experimental Pathology Consultancy, Benfleet, United Kingdom, 3SD Analytics, Bellem, Belgium, 42-Bridge, Zoersel, Belgium

    Background/Purpose: Systemic lupus erythematosus (SLE) is a complex, heterogeneous autoimmune disease. There is still a high unmet need to improve current treatment options. Type 1…
  • Abstract Number: 2407 • ACR Convergence 2023

    Immuno-permissive Antigen-presenting Cells in Giant Cell Arteritis

    Shozo Ohtsuki1, Chenyao Wang2, Ryu Watanabe3, Hui Zhang3, Mitsuhiro Akiyama3, Kenneth Warrington4, Gerald J. Berry3, Jorg Goronzy4 and Cornelia M. Weyand5, 1Mayo Clinic College of Medicine and Science, Stanford University School of Medicine, Rochester, MN, 2Mayo Clinic College of Medicine and Science, Rochester, MN, 3Stanford University School of Medicine, Stanford, CA, 4Mayo Clinic, Rochester, MN, 5Mayo Clinic School of Medicine and Stanford University, Rochester, MN

    Background/Purpose: Giant cell arteritis (GCA) is a medium and large vessel vasculitis with pathognomonic granulomatous infiltrates in the vessel wall. During the early stages of…
  • Abstract Number: 0892 • ACR Convergence 2023

    Single-Cell RNA Sequencing Reveals Keratinocytes and Fibroblasts Drive Hippo and TGFb Dysregulation and Fibrosis in Epidermal Overexpression of VGLL3 in Cutaneous Lupus

    Mehrnaz Gharaee-Kermani1, Allison Billi1, Jacob Martens1, Marisa Hildebrandt1, Amanda Victory1, Mitra Maz2, Shannon Loftus1, J. Michelle Kahlenberg1 and Johann E. Gudjonsson1, 1University of Michigan, Ann Arbor, MI, 2University of Michigan Medical School, Ann Arbor, MI

    Background/Purpose: Fibrosis is characterized by collagen deposition, fibro/myofibroblast (MYOFB) accumulation, and extracellular matrix remodeling. In some subtypes of cutaneous lupus erythematosus (CLE), particularly discoid lupus…
  • Abstract Number: 2427 • ACR Convergence 2023

    Degranulating PR3+ Myeloid Cells Characterize Proliferative Lupus Nephritis

    Alessandra Ida Celia1, Xiaoping Yang2, Hana Minsky2, Silvia Malvica2, Michelle Petri3, the Accelerating Medicines Partnership in RA/SLE4, Avi Rosenberg5 and Andrea Fava2, 1John Hopkins University of Medicine, Rome, Italy, 2Johns Hopkins University, Baltimore, MD, 3Department of Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Timonium, MD, 4Multiple, Multiple, 5Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: As part of the Accelerating Medicines Partnership (AMP), we discovered that urinary PR3, a neutrophil degranulation product, is associated with histological activity, indicating the…
  • Abstract Number: 0894 • ACR Convergence 2023

    The Cellular and Spatial Type I Interferon Response Following Skin Exposure to Ultraviolet Light

    Jie An1, Xizhang Sun1, Rayan Najjar1, Connie Zhao1, Paul Kong2, Stephanie Weaver2, Amanda Koehne2, Matt Fitzgibbon2 and Keith Elkon1, 1University of Washington, Seattle, WA, 2Fred Hutchinson Cancer Center, Seattle, WA

    Background/Purpose: SLE patients characteristically have a prominent type I interferon (IFN-I) signature in lesional and non-lesional skin. We recently demonstrated that, following a single exposure…
  • Abstract Number: 2440 • ACR Convergence 2023

    Synovial Shaping of Skin-derived Migrating Immune Cells Determines Initiation of Inflammation in Psoriatic Arthritis

    Maria Gabriella Raimondo1, Simon Rauber2, Hashem Mohammadian3, Mario Angeli1, Cong Xu1, Aleix Rius Rigau4, Markus Luber1, Hannah Labinsky5, Alina Ramming1, Stefano Alivernini6, Jörg Distler1, Ursula Fearon7, Douglas Veale8, Michael Sticherling9, Juan D Canete10, Georg Schett11 and Andreas Ramming1, 1Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany; Deutsches Zentrum für Immuntherapie, Friedrich Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, 23 Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany. 4 Deutsches Zentrum für Immuntherapie, Friedrich Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany., Erlangen, Germany, 3Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany. Deutsches Zentrum für Immuntherapie, Friedrich Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, 4Department of Internal Medicine 3, Rheumatology and Clinical Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany; Deutsches Zentrum Immuntherapie (DZI), FAU Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany, 5Medical Department II, Rheumatology, University Hospital Würzburg, Würzburg, Germany, 6Immunology Research Core Facility, Gemelli Science and Technology Park, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Division of Rheumatology - Fondazione Policlinico Universitario A. Gemelli IRCCS - Università Cattolica del Sacro Cuore, Rome, Italy, 7Trinity College Dublin, Dublin, Ireland, 8St.Vincent's University Hosp, Dublin, Ireland, 9Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg & Universitätsklinikum Erlangen, Department of Dermatology, Erlangen, Germany, 10Hospital Clinic an IDIBAPS, Barcelona, Spain, 11Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

    Background/Purpose: Around 30% of the patients with psoriasis (PsO) develop psoriatic arthritis (PsA) overtime, suggesting the existence of a disease mediated skin-joint crosstalk. To date,…
  • Abstract Number: 0905 • ACR Convergence 2023

    Low-Density Granulocytes and Neutrophil Extracellular Traps in Incomplete Systemic Lupus Erythematosus

    Svenja Henning1, Tobias Reimers2, Berber Doornbos-van der Meer2, Barbara Horvath3, Hendrika Bootsma4, Karina de Leeuw2 and Johanna Westra2, 1University Medical Center Groningen, Department of Rheumatology and Clinical Immunology, Groningen, Netherlands, 2University Medical Center Groningen, Groningen, Netherlands, 3University Medical Center Groningen / Department of Dermatology, Groningen, Netherlands, 4Department of Rheumatology, University Medical Centre Groningen, Groningen, Netherlands

    Background/Purpose: Incomplete SLE (iSLE) defines a group of patients with symptoms typical of SLE but not meeting sufficient criteria required for the classification of SLE.…
  • Abstract Number: 2442 • ACR Convergence 2023

    Neutrophils Induce Contact-Dependent Expansion of Arthritogenic Th17 Cells and Are Necessary for Disease in Experimental Ankylosing Spondylitis

    Hillary Struthers1, Emily Vance1, Kofi Asare-Konadu1, Holly Rosenzweig2 and Ruth Napier1, 1Oregon Health & Science University, Portland, OR, 2VA Portland Healthcare System, Portland, OR

    Background/Purpose: Ankylosing spondylitis (AS) patients have irregular neutrophil responses, as indicated clinically by neutrophilia and increased neutrophil to lymphocyte ratios that positively associate with disease…
  • Abstract Number: 0911 • ACR Convergence 2023

    Spatial Transcriptomics Reveals Normal-density and Low-density Neutrophils Are More Prevalent Than Macrophages in Lupus Nephritis Glomeruli, and Urine DNA Methylation Analyses Capture Both Myeloid Populations

    Sladjana Skopelja-Gardner1, Joshua Skydel2, Alecia Roy3, Brenna Kerin3, James Whitley3, Fred Kolling4, Noelle Kosarek4, Michelle Petri5, Andrea Fava6, Lucas Salas7 and Christopher Burns3, 1Department of Medicine, Dartmouth Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, 2Dartmouth-Hitchcock Medical Center, Lebanon, NH, 3Dartmouth Hitchcock Medical Center, Lebanon, NH, 4Geisel School of Medicine at Dartmouth, Hanover, NH, 5Department of Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Timonium, MD, 6Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 7Department of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, NH

    Background/Purpose: Despite compelling evidence that normal-density (NDN) and low-density neutrophils (LDN) are activated in the blood of lupus patients, their role in lupus nephritis (LN)…
  • Abstract Number: 2600 • ACR Convergence 2023

    Clonal Hematopoiesis Is Associated with Giant Cell Arteritis

    Background/Purpose: Giant cell arteritis (GCA) is an age-related vasculitis of large and medium vessels. Prior population studies have identified an association between GCA and hematologic…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 14
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology